Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
A distinctive feature of HCV is that its life cycle depends on lipoprotein metabolism. Viral morphogenesis and secretion follow the very low-density lipoprotein (VLDL) biogenesis pathway and, consequently, infectious HCV in the serum is associated with triglyceride-rich lipoproteins (TRL). Lipoprote...
Guardado en:
Autores principales: | Patrick Maillard, Marine Walic, Philip Meuleman, Farzin Roohvand, Thierry Huby, Wilfried Le Goff, Geert Leroux-Roels, Eve-Isabelle Pécheur, Agata Budkowska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f98f4b688604b5890b734ac5cde75fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of a functional, CRM-1-dependent nuclear export signal in hepatitis C virus core protein.
por: Andrea Cerutti, et al.
Publicado: (2011) -
CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
por: A. Budkowska
Publicado: (2018) -
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
por: Sumeet A Khetarpal, et al.
Publicado: (2021) -
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome
por: Dominic C Chow, et al.
Publicado: (2008) -
Encephalomyocarditis Virus Entry Unveiled
por: Sara Cherry
Publicado: (2019)